BIO-OPTIONS, INC.

BIO-OPTIONS, INC. is a physician-owned biotechnology and pharmaceutical startup based in the United States, established in 2003. The company's slogan, "We offer fresh, frozen and formalin-fixed paraffin-embedded tissue specimens of all major diseases," reflects its core offering of human biospecimens for research. BIO-OPTIONS designs prospective specimen collection protocols specifically tailored to meet the requirements of clients' research studies. They maintain a large in-house library of banked biospecimens, including FFPE tissue blocks, frozen tissue and blood, and other biological materials, accompanied by associated clinical data and biomarker status at the time of collection. In addition, the company can retrospectively test banked specimens for newly discovered biomarkers, thus significantly increasing the number of specimens available for research studies. BIO-OPTIONS understands the needs of research scientists, surgeons, and clinical specimen providers, ensuring proper protocols, consents, and comprehensive sample annotation. Their nationwide network of US community hospitals and clinics provides an unsurpassed ability to meet the needs of research groups. With an emphasis on delivering highest quality biospecimens, BIO-OPTIONS has established ongoing programs with many pharmaceutical and diagnostics companies, both large and small. The company is frequently cited as a specimen provider in major biotech and biopharm publications and patents. With a track record of excellence in providing biospecimens for research, BIO-OPTIONS presents a compelling opportunity for potential venture capital investors looking to tap into the biotechnology and pharmaceutical sectors.